Alzheimer Disease & Dementia

Lithium: what’s its history and where do we still need more information?

What are the available and upcoming AD treatments and how can you utilize them to best serve your patients?

The experts weighed in on a wide variety of psychiatric issues for the January 2023 issue of Psychiatric Times.

Alzheimer disease research may offer the key to effective treatment for former athletes.

From current treatments for cannabis use disorder to new possibilities for the treatment of dementia, here are highlights from the week in Psychiatric Times.

"Dementia is a mental health condition that can make or break families. Remember that behind the difficult behavior is your loved one."

What's the latest in dementia?

"To be sure, we are still in the nascent stages of developing treatments. However, our armamentarium is steadily growing."

From evidence-based novel therapies for bipolar depression to potential indicators of early-stage Alzheimer disease, here are highlights from the week in Psychiatric Times.

New research finds that a urine test for formic acid could detect early-stage Alzheimer disease.

From the cross-cultural dimensions of psychosis to the economic burden of schizophrenia, here are highlights from the week in Psychiatric Times.

Results show comparisons between intranasal and intracerebroventricular distribution of an oxytocin derivative.

From the relationship between psychotic disorders and dementia risk to the major differences between bipolar I and bipolar II, here are highlights from the week in Psychiatric Times.

Individuals with a psychotic disorder are 2.5 times more likely than those without one to develop dementia.

According to new research, treating depression in older adults could decrease risk of dementia by 51%.

From herbal medicine for psychiatrists to the psychiatric implications of the Parkland School massing shooting, here are highlights from the week in Psychiatric Times.

Can Alzheimer disease research offer the key to effective treatment?

A reminder to cherish your parents and the older adults in your life.

Alzheimer disease psychosis treatment pimavanserin receives Complete Response Letter from the FDA.

Is our research about Alzheimer disease wrong?

Study shows promising results for early detection and prevention efforts.

If we don't find a cure or adequate treatments, the number of individuals impacted by dementia could skyrocket to nearly 14 or 15 million Americans by 2050.

Top-line data for study is expected in late 2022, early 2023.

Compelling new book discusses love, Alzheimer disease, and medical aid in dying.

Individuals with depression may be at a greater risk to develop late-onset Alzheimer disease, but a new study suggests depression onset may help predict Alzheimer disease.